Walmart reported a 5.9% revenue increase to $187.9 billion, beating expectations and raising its full-year outlook, but its U.S. comparable sales grew just 2.6%, disappointing investors. The main cause was falling prescription drug prices in its pharmacy business, which reduced sales growth by about 0.8 to 0.9 percentage points. Excluding this, sales growth would have been closer to 3.4%, aligning better with expectations. This price drop reflects federal policies lowering drug costs, benefiting consumers by making medications more affordable, not a sign of weaker demand. Inflation is still influencing shopping patterns, with higher-income shoppers trading down to Walmart while lower-income consumers spend less, but the pharmacy price effect is the key factor behind the sales miss.
Walmart's stock fell 8% following its Q2 FY27 report, which showed revenue growth above estimates but the slowest U.S. same-store sales growth since 2020 at 2.6%, below forecasts. The company also issued weaker Q3 guidance, citing a timing shift in F...
Walmart reported a 24% increase in U.S. e-commerce sales in the second quarter, fueled by strong performance in store-fulfilled pickup, delivery, advertising, and its online marketplace. This growth contributed to a 5.9% rise in total revenue to $187...
Amazon announced plans to expand its Prime Air drone delivery service to nearly 500 U.S. cities by the end of 2026, aiming to fulfill Jeff Bezos' decade-old vision of fast, autonomous package delivery. Despite making hundreds of thousands of deliveri...
Walmart received nearly $3 billion in tariff refunds, which significantly boosted its quarterly profits and allowed the company to invest in lowering prices for customers. The refunds contributed a 750-basis-point net benefit to adjusted operating in...
Walmart will report its fiscal second-quarter earnings, providing insight into U.S. consumer health amid a divided economy. The company, which focuses on value for lower-income shoppers while attracting higher-income customers, faces challenges from ...
